Interact to see
Advertisement
Advertisement
BKN vs NUV
BKN vs NUV Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
BKN vs. NUV commentary
Jul 28, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BKN is a Hold and NUV is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
NUV has more net assets: 1.83B vs. BKN (198M). NUV has a higher annual dividend yield than BKN: NUV (2.068) vs BKN (-2.358). BKN was incepted earlier than NUV: BKN (32 years) vs NUV (38 years). NUV (0.47) has a lower expense ratio than BKN (1.54). BKN has a higher turnover NUV (21.00) vs NUV (21.00).
| BKN | NUV | BKN / NUV | |
| Gain YTD | -2.358 | 2.068 | -114% |
| Net Assets | 198M | 1.83B | 11% |
| Total Expense Ratio | 1.54 | 0.47 | 328% |
| Turnover | 42.00 | 21.00 | 200% |
| Yield | 4.94 | 4.22 | 117% |
| Fund Existence | 32 years | 38 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| BKN | NUV | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 88% | 3 days ago 70% |
| Stochastic ODDS (%) | 3 days ago 83% | 3 days ago 82% |
| Momentum ODDS (%) | 3 days ago 77% | 3 days ago 69% |
| MACD ODDS (%) | 3 days ago 78% | 3 days ago 76% |
| TrendWeek ODDS (%) | 3 days ago 75% | 3 days ago 70% |
| TrendMonth ODDS (%) | 3 days ago 72% | 3 days ago 74% |
| Advances ODDS (%) | 26 days ago 82% | 3 days ago 76% |
| Declines ODDS (%) | 5 days ago 81% | 5 days ago 76% |
| BollingerBands ODDS (%) | 3 days ago 90% | 3 days ago 83% |
| Aroon ODDS (%) | 3 days ago 79% | 3 days ago 70% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ASVIX | 10.10 | 0.06 | +0.60% |
| American Century Small Cap Value Inv | |||
| VITSX | 152.68 | 0.67 | +0.44% |
| Vanguard Total Stock Market Idx I | |||
| GCLLX | 17.21 | 0.06 | +0.35% |
| Goldman Sachs Enhanced U.S. Equity C | |||
| VECRX | 22.33 | 0.07 | +0.31% |
| Virtus KAR Equity Income R6 | |||
| FBTTX | 25.58 | N/A | N/A |
| Fidelity Advisor Biotechnology M | |||